Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,222 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Potential synergy between radiotherapy and CAR T-cells - a multicentric analysis of the role of radiotherapy in the combination of CAR T cell therapy.
Fan J, Adams A, Sieg N, Heger JM, Gödel P, Kutsch N, Kaul D, Teichert M, von Tresckow B, Bücklein V, Goesmann G, Li M, Struve N, Trommer M, Linde P, Rosenbrock J, Celik E, Penack O, Stuschke M, Subklewe M, Belka C, von Bergwelt-Baildon M, Borchmann P, Marnitz S, Baues C. Fan J, et al. Among authors: adams a. Radiother Oncol. 2023 Jun;183:109580. doi: 10.1016/j.radonc.2023.109580. Epub 2023 Feb 25. Radiother Oncol. 2023. PMID: 36842663
Addition of Radiotherapy to Immunotherapy: Effects on Outcome of Different Subgroups Using a Propensity Score Matching.
Trommer M, Kinsky J, Adams A, Hellmich M, Schlaak M, von Bergwelt-Baildon M, Celik E, Rosenbrock J, Morgenthaler J, Herter JM, Linde P, Mauch C, Theurich S, Marnitz S, Baues C. Trommer M, et al. Among authors: adams a. Cancers (Basel). 2020 Aug 27;12(9):2429. doi: 10.3390/cancers12092429. Cancers (Basel). 2020. PMID: 32867046 Free PMC article.
Oncologic Outcome and Immune Responses of Radiotherapy with Anti-PD-1 Treatment for Brain Metastases Regarding Timing and Benefiting Subgroups.
Trommer M, Adams A, Celik E, Fan J, Funken D, Herter JM, Linde P, Morgenthaler J, Wegen S, Mauch C, Franklin C, Galldiks N, Werner JM, Kocher M, Rueß D, Ruge M, Meißner AK, Baues C, Marnitz S. Trommer M, et al. Among authors: adams a. Cancers (Basel). 2022 Feb 27;14(5):1240. doi: 10.3390/cancers14051240. Cancers (Basel). 2022. PMID: 35267546 Free PMC article.
Impact of the COVID-19 pandemic on training conditions and education in oncologic disciplines: a survey-based analysis.
Trommer M, Adams A, Bürkle C, Brunner S, Grandoch A, Geffroy A, Franklin C, Gassa A, Meißner AK, Mellinghoff S, Sharma SJ, Schrittenlocher S, Witte L, Marnitz S. Trommer M, et al. Among authors: adams a. Strahlenther Onkol. 2023 Sep;199(9):806-819. doi: 10.1007/s00066-023-02121-6. Epub 2023 Aug 4. Strahlenther Onkol. 2023. PMID: 37540263 Free PMC article.
First-line therapy for adults with advanced renal cell carcinoma: a systematic review and network meta-analysis.
Aldin A, Besiroglu B, Adams A, Monsef I, Piechotta V, Tomlinson E, Hornbach C, Dressen N, Goldkuhle M, Maisch P, Dahm P, Heidenreich A, Skoetz N. Aldin A, et al. Among authors: adams a. Cochrane Database Syst Rev. 2023 May 4;5(5):CD013798. doi: 10.1002/14651858.CD013798.pub2. Cochrane Database Syst Rev. 2023. PMID: 37146227 Free PMC article. Review.
Multiple drug combinations of bortezomib, lenalidomide, and thalidomide for first-line treatment in adults with transplant-ineligible multiple myeloma: a network meta-analysis.
Piechotta V, Jakob T, Langer P, Monsef I, Scheid C, Estcourt LJ, Ocheni S, Theurich S, Kuhr K, Scheckel B, Adams A, Skoetz N. Piechotta V, et al. Among authors: adams a. Cochrane Database Syst Rev. 2019 Nov 25;2019(11):CD013487. doi: 10.1002/14651858.CD013487. Cochrane Database Syst Rev. 2019. PMID: 31765002 Free PMC article.
3,222 results